Berger Dietmar 4
4 · Atara Biotherapeutics, Inc. · Filed Feb 8, 2019
Insider Transaction Report
Form 4
Berger Dietmar
Global Head of R&D
Transactions
- Award
Common Stock
2019-02-06+25,000→ 75,000 total - Award
Employee Stock Option (Right to Buy)
2019-02-06+50,000→ 50,000 totalExercise: $38.47Exp: 2029-02-05→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]These restricted stock units vest in four equal annual installments on each of the first, second, third and fourth anniversaries of the grant date, subject to the reporting person's continuous service.
- [F2]1/48th of the shares subject to the stock option vest and become exercisable each month following February 6, 2019, subject to the reporting person's continuous service.